It has been demonstrated that the presence of tumor-infiltrating lymphocytes in breast carcinomas associated with the production of potentially anti-inflamatory cytokines, such as IL-4, IL-10, and TGF-β would be associated with an immunomodulatory microenvironment, triggering mechanism of tumor escape from the immune system [17]. This evidence concerns the gene IL10 and breast carcinoma.